Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Latest news on TEVA PHARMACEUTICAL INDUST
06/18TEVA PHARMACEUTICAL INDUSTRIES : Negative trial result hardly dents Teva share p..
AQ
06/15UK's Indivior will fight U.S. FDA's approval for copycat drug
RE
06/15TEVA PHARMACEUTICAL INDUSTRIES : Provides Update on Clinical Trial of Fremanezum..
BU
06/11TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Today's Research Reports on Trending Tick..
AC
06/06TEVA PHARMACEUTICAL INDUSTRIES LTD : Submission of Matters to a Vote of Security..
AQ
06/05TEVA PHARMACEUTICAL INDUSTRIES : Releases Survey Highlighting Needs of Caregiver..
AQ
06/05TEVA PHARMACEUTICAL INDUSTRIES : diffuse un sondage dévoilant les besoins des ai..
AQ
06/04Aimovig price improves ICER's migraine outlook
AQ
06/03CITI : Limit exposure to Teva bonds
AQ
05/31TEVA PHARMACEUTICAL INDUSTRIES : Confirms September PDUFA Date for Fremanezumab
AQ
05/31TEVA PHARMACEUTICAL INDUSTRIES : Announces Publication of Phase III Trial Data o..
AQ
05/28MANAGEMENT TRACKS : ISA, ImCheck, ArQule
AQ
05/24JOHN WOOD : Wins "Multi-Million" Dollar Contract With Teva Biotech
AQ
05/23TEVA PHARMACEUTICAL INDUSTRIES : FDA to respond to Teva migraine drug applicatio..
AQ
05/23TEVA PHARMACEUTICAL INDUSTRIES : Confirms September PDUFA Date for Fremanezumab
BU
05/21ACTELION : Teva on FDA name and shame list
AQ
05/21TEVA PHARMACEUTICAL INDUSTRIES : Israel’s Teva on FDA blacklist of drugmak..
AQ
05/18TEVA PHARMACEUTICAL INDUSTRIES : CORRECTING and REPLACING Teva Announces Publica..
PU
05/18TEVA PHARMACEUTICAL INDUSTRIES LTD ( : Free Stock Performance Review on Teva Pha..
AC
05/18FDA approves Aimovig as first CGRP inhibitor for migraines
AQ
05/18Hikma reaffirms full-year revenue forecast, cites better generics business
RE
05/17BERKSHIRE HATHAWAY : Buffett's Berkshire Hathaway doubles its stake in Teva
AQ
05/16BERKSHIRE HATHAWAY : Buffett's Berkshire Hathaway doubles its stake in Teva
AQ
05/16Berkshire Increases Stake in Teva, Monsanto
AQ
05/15Florida and Texas Are Among Latest States to Sue Opioid Painkiller Companies
DJ
05/15TEVA PHARMACEUTICAL INDUSTRIES : CORRECTING and REPLACING Teva Announces Publica..
BU
05/13PERRIGO : FDA delays approving Perrigo's generic Teva inhaler
AQ
05/12GLOBAL PRIMARY PROGRESSIVE MULTIPLE : F. Hoffmann-La Roche Ltd.: 9strategy.biz ..
AQ
05/11FDA Rejects Perrigo's ProAir Generic, Drug Maker Says
DJ
05/10TEVA PHARMACEUTICAL INDUSTRIES : Presents New Long-Term Data Demonstrating Effic..
AQ
05/09MYLAN : May Be Gem in Rough Generic Sector
DJ
05/09TEVA PHARMACEUTICAL INDUSTRIES : Reports First Quarter 2018 Financial Results
AQ
05/09CTI BIOPHARMA : Reports First Quarter 2018 Financial Results
AQ
05/07TEVA PHARMACEUTICAL INDUSTRIES : to Present AUSTEDO Tablets Data at the American..
AQ
05/04TEVA PHARMACEUTICAL INDUSTRIES : Globes, Tel Aviv, Israel, Eli Tsipori column
AQ
05/04TEVA PHARMACEUTICAL INDUSTRIES : reports jump in first-quarter earnings, raises ..
AQ
05/04Teva reveals delay in migraine timeline, reports earnings
AQ
05/04Amgen says ICER underestimates migraine patient burden
AQ
05/03TEVA PHARMACEUTICAL INDUSTRIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCI..
AQ
05/03TEVA PHARMACEUTICAL INDUSTRIES : raises 2018 guidance despite 40% plunge in US C..
AQ
05/03TEVA PHARMACEUTICAL INDUSTRIES : to Report First Quarter 2018 Financial Results ..
AQ
05/03Teva raises 2018 outlook, expects migraine drug approval by year-end
RE
05/03TEVA PHARMACEUTICAL INDUSTRIES (NYSE : TEVA) reported earnings of $0.94 per shar..
AQ
05/03TEVA PHARMACEUTICAL INDUSTRIES : Raises Outlook After 1Q Results
DJ
05/03TEVA PHARMACEUTICAL INDUSTRIES : reports jump in first-quarter earnings, raises ..
AQ
05/03TEVA PHARMACEUTICAL INDUSTRIES LTD : Results of Operations and Financial Conditi..
AQ
05/03TEVA PHARMACEUTICAL INDUSTRIES : Reports First Quarter 2018 Financial Results
BU
05/03TEVA PHARMACEUTICAL INDUSTRIES : not selling SLE logistics unit
AQ
05/03NEW FRONT IN OPIOID LAWSUITS : Rise in Insurance Premiums -- WSJ
DJ
05/02TEVA PHARMACEUTICAL INDUSTRIES : not selling SLE logistics unit
AQ
05/02NEW FRONT ON OPIOID LITIGATION : Suits Over Rising Premiums
DJ
05/02TEVA PHARMACEUTICAL INDUSTRIES : to Present AUSTEDO® (deutetrabenazine) Tablets ..
BU
05/02Indivior's first-quarter profit slips, shares fall on top drug let-down
RE
05/02TEVA PHARMACEUTICAL INDUSTRIES : Presents New Long-Term Data Demonstrating Effic..
AQ
04/30TEVA PHARMACEUTICAL INDUSTRIES : changing profit breakdown
AQ
04/29TEVA PHARMACEUTICAL INDUSTRIES : Court delays layoffs at Teva Ashdod
AQ
04/27TEVA PHARMACEUTICAL INDUSTRIES : Presents New Long-Term Data Demonstrating Effic..
BU
04/27TEVA PHARMACEUTICAL INDUSTRIES LTD : Regulation FD Disclosure, Financial Stateme..
AQ
04/27TEVA PHARMACEUTICAL INDUSTRIES : Three Teva directors to leave board
AQ
04/26TEVA PHARMACEUTICAL INDUSTRIES : Three Teva directors to leave board
AQ
04/26TEVA PHARMACEUTICAL INDUSTRIES : and the Procter & Gamble Company Have Agreed to..
AQ
04/26TEVA PHARMACEUTICAL INDUSTRIES : to Report First Quarter 2018 Financial Results ..
AQ
04/26TEVA PHARMACEUTICAL INDUSTRIES : to reduce size of board after June shareholders..
RE
04/24TEVA PHARMACEUTICAL INDUSTRIES : Histadrut slams Teva management over Ashdod pla..
AQ
04/24PROCTER & GAMBLE : Teva and the Procter & Gamble Company Have Agreed to Terminat..
AQ
04/24PROCTER & GAMBLE : P&G Announces Third Quarter Earnings
AQ
04/23TEVA PHARMACEUTICAL INDUSTRIES : to Report First Quarter 2018 Financial Results ..
BU
04/23PROCTER & GAMBLE : P&G Announces Third Quarter Earnings; Net Sales +4%; Organic ..
AQ
04/23P&G Acquires the Consumer Health Business of Merck KGaA, Darmstadt, Germany
AQ
04/20TEVA PHARMACEUTICAL INDUSTRIES : to Present New Data across Multiple Therapeutic..
AQ
04/19PAXMAN PUBL : receives market approval in Mexico and plans Q2 launch with licens..
AQ
04/19P&G Acquires the Consumer Health Business of Merck KGaA, Darmstadt, Germany; ..
AQ
04/19TEVA PHARMACEUTICAL INDUSTRIES : and the Procter & Gamble Company Have Agreed to..
BU
04/17TEVA PHARMACEUTICAL INDUSTRIES : to Present New Data Across Multiple Therapeutic..
BU
04/16HISTADRUT : Teva ignoring potential Ashdod plant buyers
AQ
1  2  3  4  5  6  7  8  9  10Next
Financials ($)
Sales 2018 19 600 M
EBIT 2018 -
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales 2018 1,24x
Capi. / Sales 2019 1,25x
Capitalization 24 291 M
Chart TEVA PHARMACEUTICAL INDUST
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 19,5 $
Spread / Average Target -18%
Managers
NameTitle
Kåre Schultz President, Chief Executive Officer & Director
Sol J. Barer Chairman
Carlo de Notaristefani Executive Vice President-Global Operations
Michael McClellan Chief Financial Officer & Executive Vice President
Amir Elstein Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED30.84%23 937
JOHNSON & JOHNSON-12.25%328 858
PFIZER0.39%212 690
NOVARTIS-8.25%193 330
ROCHE HOLDING LTD.-14.81%184 168
MERCK AND COMPANY8.39%166 880